Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Strategies & Market Trends : Anthony @ Equity Investigations, Dear Anthony, -- Ignore unavailable to you. Want to Upgrade?

To: KZAP who wrote (79852)	8/28/2002 6:57:39 PM
From: bigbuk	Read Replies (2) \| Respond to of 122087

PANAE Panamed Corp (OTC BB) 8/28/2002 10:34 AM hide quote detailed quote options chain add to favorites list favorites chart help Last: 0.93 Change: UNCH Open: 0.93 High: 0.93 Low: 0.93 Volume: 100 Percent Change: n/a Yield: n/a P/E Ratio: 31.00 52 Week Range: 0.30 to 13.50 Please get your facts straight, BTW > can you still smile and scream "HAPPY INVESTING" with your mouth full of shit? also same deal here ? stockpatrol.com PANAMED CORPORATION (OTCBB: PANA), PART I – AFRICAN ADVENTURES June 24, 2002 Several internet newsletters have begun touting the prospects of PanaMed Corporation (OTCBB: PANA), an under-capitalized, over-the-counter company that has announced plans to test an unproven HIV/AIDS therapy in an unidentified African nation. The promoters gloss over such details. Still, the newsletters claim to be “more than a little excited” about PanaMed. Perhaps that’s because the newsletter owner, Market Pathways Financial Relations Incorporated, received 40,000 restricted common shares of PanaMed common stock as payment for distributing these “reports” and “future advertising services.” A pattern had emerged. As public investors became aware of the Company’s claims – to a therapeutic product that had a number of advantages over conventional AIDS medications – trading volume rose, but stock prices dropped. The pattern shifted once again on March 8th. The impact of the March 5th press release had faded. Volume was just 800 shares, but now market makers lifted the stock price dramatically, to $6.75 a share. The second press release, issued on March 11th, was a virtual repeat of the first, and generated far less frenzy for PanaMed stock. Share prices continued to rise, to $7.50 on March 12th, as volume increased slightly to 1,900 shares. By the next day, March 13th, share prices had dropped to $6, and only 400 shares were traded. By June 19th, the price of PanaMed shares had decreased considerably, to around $2 a share. PANA there's a little pain there I'll have to admit. However the share price today is .76 x 1.01 with the last trade @ .93, So the .50'ish you posted is off quite a bit. SETO is a solid little company, I've always done very good with that one. Do you know anyone else who bought that one @ .30 and sold it as high as $2.96? Well I was fortunate enough to have done that. BTW, SETO hit a 52 week high this week! Yes, Happy Investing! KZAP